MedPath
NMPA Approval

Lorlatinib Tablets

国药准字HJ20220040

April 27, 2022

Drug Information

洛拉替尼片

博瑞纳

片剂

25mg

化学药品

April 27, 2022

April 26, 2027

Company Information

Applicant Company

Boulevard de la Plaine 17, 1050 Bruxelles, Belgium

Manufacturing Company

Betriebsstatte Freiburg, Mooswaldallee 1, 79090 Freiburg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.